Evidence map›Paper›PMID 22728937›Full record

ArticleThe Journal of clinical investigation2012

Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.

Linda K Bockenstedt, David G Gonzalez, Ann M Haberman, Alexia A Belperron

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed, 3 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 3 syntheses or guidelines pooled it, 214 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Xenodiagnosis to Search for Borrelia burgdorferi After Antibiotic Treatment of Lyme Disease: A Prospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  5. Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Trial
  6. Protective efficacy of mutant strains ofInfection and immunity · 2026
    Article
  7. Article
  8. Glycolytic reprogramming in host response toExperimental and therapeutic medicine · 2026
    Article
  9. Lyme borreliosis.Nature reviews. Disease primers · 2026
    Review
  10. Characterization ofMicroorganisms · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in immunology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. The peptidoglycan ofScience translational medicine · 2025
    Article

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Linda K BockenstedtDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
David G Gonzalez
Ann M Haberman
Alexia A Belperron
Yale University · US

Funding

Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, WARREN D · 2007 to 2017
$7.0M
Real-time Imaging Analysis of Vector-borne Lyme Borreliosis Pathogenesis & PersisR01AI085798 · NIAID · YALE UNIVERSITY · PI BOCKENSTEDT, LINDA K. · 2010 to 2014
$2.1M
Innate Immunity in Vector-Borne Lyme BorreliosisU01CI000159 · CI · YALE UNIVERSITY · PI BOCKENSTEDT, LINDA K · 2004 to 2007
$397k
NCPDCID CDC HHS U01 CI000159NIAID NIH HHS R01 AI085798NIAID NIH HHS R01AI0857981NIAMS NIH HHS P30 AR053495NIAMS NIH HHS P30AR053495
6 · The paper itself

Abstract

An enigmatic feature of Lyme disease is the slow resolution of musculoskeletal symptoms that can continue after treatment, with some patients developing an inflammatory arthritis that becomes refractory to antibiotic therapy. Using intravital microscopy and the mouse model of Lyme borreliosis, we observed that Borrelia burgdorferi antigens, but not infectious spirochetes, can remain adjacent to cartilage for extended periods after antibiotic treatment. B. burgdorferi was not recovered by culture or xenodiagnosis with ticks after antibiotic treatment of WT mice and all but one of the immunodeficient mice with heightened pathogen burden due to impaired TLR responsiveness. Amorphous GFP+ deposits were visualized by intravital microscopy in the entheses of antibiotic-treated mice infected with GFP-expressing spirochetes and on the ear cartilage surface in sites where immunofluorescence staining detected spirochete antigens. Naive mice were not infected by tissue transplants from antibiotic-treated mice even though transplants contained spirochete DNA. Tissue homogenates from antibiotic-treated mice induced IgG reactive with B. burgdorferi antigens after immunization of naive mice and stimulated TNF-α production from macrophages in vitro. This is the first direct demonstration that inflammatory B. burgdorferi components can persist near cartilaginous tissue after treatment for Lyme disease. We propose that these deposits could contribute to the development of antibiotic-refractory Lyme arthritis.

Indexed as

AnimalsAnti-Bacterial AgentsAntigens, BacterialArthritis, InfectiousBacterial LoadBorrelia burgdorferiCartilageCeftriaxoneDoxycyclineEar, ExternalFemaleFluorescence Recovery After PhotobleachingGreen Fluorescent ProteinsJoint CapsuleLyme DiseaseMiceAnti-Bacterial AgentsAntigens, BacterialCeftriaxoneDoxycyclineGreen Fluorescent ProteinsMyd88 protein, mouseMyeloid Differentiation Factor 88Recombinant Proteins

Identifiers

PMID22728937
PMCPMC3386809
OpenAlexW2015096711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.